Trials that use: Risk difference
New to this method? Read the tutorial →
6,276 results
- Relative Bioavailability Study of Ropinirole Implants in Parkinson’s Patients on L-Dopa Switched From Oral Ropinirole: Complete Statistical AnalysisIndependent statistical analysis of Relative Bioavailability Study of Ropinirole Implants in Parkinson's Patients on L-Dopa Switched From Oral Ropinirole: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Relative Exposure and Safety Study of Kimyrsa in ABSSSI Patients: Complete Statistical AnalysisIndependent statistical analysis of Relative Exposure and Safety Study of Kimyrsa in ABSSSI Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03873987).
- Relative Patient Benefits of a Hospital-PCMH Collaboration Within an ACO to Improve Care Transitions: Complete Statistical AnalysisIndependent statistical analysis of Relative Patient Benefits of a Hospital-PCMH Collaboration Within an ACO to Improve Care Transitions: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- RELAX-AHF-2Independent statistical analysis of Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in AHF: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- RELAX-AHF-EUIndependent statistical analysis of Effect of Serelaxin Versus Standard of Care in Acute Heart Failure (AHF) Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- RELEASEIndependent statistical analysis of PCI Treatment/Gemcitabine & Chemotherapy vs Chemotherapy Alone in Patients With Inoperable Extrahepatic Bile Duct Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Reliability and Equivalence of Alternate Forms of the Digital Clock Drawing Test: Complete Statistical AnalysisIndependent statistical analysis of Reliability and Equivalence of Alternate Forms of the Digital Clock Drawing Test: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- RELIEFIndependent statistical analysis of LINX Reflux Management System in Subjects With GERD Who Have Previously Undergone a Laparoscopic Sleeve Gastrectomy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- RELIEFIndependent statistical analysis of REstrictive Versus LIbEral Fluid Therapy in Major Abdominal Surgery: RELIEF Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Relieving Acute Pain (RAP) Study: A Pilot Study: Complete Statistical AnalysisIndependent statistical analysis of Relieving Acute Pain (RAP) Study: A Pilot Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03426137).
- REMAINIndependent statistical analysis of A Phase IV Study of Rebif ® 44mcg Administered Three Times Per Week by Subcutaneous Injection Compared With no Treatment in the Therapy of Relapsing Multiple Sclerosis After…
- Remicade Safety Line (Crohn’s Disease)(Study P03288)(COMPLETED): Complete Statistical AnalysisIndependent statistical analysis of Remicade Safety Line (Crohn's Disease)(Study P03288)(COMPLETED): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00818272).
- remifentanilIndependent statistical analysis of Remifentanil Only vs. Midazolam and Meperidine During Elective Colonoscopy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01693185).
- Remote Ischemic Conditioning to Enhance Resuscitation (RICE) Pilot: Complete Statistical AnalysisIndependent statistical analysis of Remote Ischemic Conditioning to Enhance Resuscitation (RICE) Pilot: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04265807).
- REMOTE-COVIDIndependent statistical analysis of Remote Monitoring Use In Cases Of Suspected COVID-19 (Coronavirus): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04337489).
- RENABLATE Feasibility Study CS156 (EC12-02) Study of Catheter Based Renal Denervation to Treat Resistant Hypertension: Complete Statistical AnalysisIndependent statistical analysis of RENABLATE Feasibility Study CS156 (EC12-02) Study of Catheter Based Renal Denervation to Treat Resistant Hypertension: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Renal Effects of Two Iodinated Contrast Media in Patients at Risk Undergoing Computed Tomography: Complete Statistical AnalysisIndependent statistical analysis of Renal Effects of Two Iodinated Contrast Media in Patients at Risk Undergoing Computed Tomography: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Renal Transplants in Hepatitis C Negative Recipients With Nucleic Acid Positive Donors: Complete Statistical AnalysisIndependent statistical analysis of Renal Transplants in Hepatitis C Negative Recipients With Nucleic Acid Positive Donors: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Renin and Renal Biomarker Response to Angiotensin II: Complete Statistical AnalysisIndependent statistical analysis of Renin and Renal Biomarker Response to Angiotensin II: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04558359).
- Reolysin in Combination With FOLFOX6 and Bevacizumab or FOLFOX6 and Bevacizumab Alone in Metastatic Colorectal Cancer: Complete Statistical AnalysisIndependent statistical analysis of Reolysin in Combination With FOLFOX6 and Bevacizumab or FOLFOX6 and Bevacizumab Alone in Metastatic Colorectal Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Repeat PET/CT Imaging of Patients With Amyloid 124I-AT-01 to Measure Changes in Organ-specific Amyloid Load: Complete Statistical AnalysisIndependent statistical analysis of Repeat PET/CT Imaging of Patients With Amyloid 124I-AT-01 to Measure Changes in Organ-specific Amyloid Load: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Repeat Quadratus Lumborum Block to Reduce Opioid Need in Patients After Pancreatic Surgery: Complete Statistical AnalysisIndependent statistical analysis of Repeat Quadratus Lumborum Block to Reduce Opioid Need in Patients After Pancreatic Surgery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Repeated Exposure to Eltrombopag in Adults With Idiopathic Thrombocytopenic Purpura (REPEAT): Complete Statistical AnalysisIndependent statistical analysis of Repeated Exposure to Eltrombopag in Adults With Idiopathic Thrombocytopenic Purpura (REPEAT): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Repetitive Transcranial Magnetic Stimulation for “Voices”: Complete Statistical AnalysisIndependent statistical analysis of Repetitive Transcranial Magnetic Stimulation for "Voices": primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00004980).
- REPLACE-BGIndependent statistical analysis of A Trial Comparing Continuous Glucose Monitoring With and Without Routine Blood Glucose Monitoring in Adults With Type 1 Diabetes: primary endpoint results, effect estimate with confidence interval, sample-size…
- REPLAYIndependent statistical analysis of Retrospective Cohort Study of Rebif® Use in Pediatric Multiple Sclerosis (MS) Subjects (REPLAY): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- REPRISE IIIIndependent statistical analysis of Safety and Efficacy Study of Lotus Valve for Transcatheter Aortic Valve Replacement: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- REQUIP RLS PMSIndependent statistical analysis of REQUIP RLS Post Marketing Surveillance: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01327339).
- RESCUEIndependent statistical analysis of Renal Safety Evaluation After Dotarem®-Enhanced MRI: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00650845).
- Research Study to Determine Sensitivity to Gentle Touch and Pressure During an Active Migraine Attack.: Complete Statistical AnalysisIndependent statistical analysis of Research Study to Determine Sensitivity to Gentle Touch and Pressure During an Active Migraine Attack.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- ReSET Aim 1b: Restarting Safe Education and Testing for Children With Medical Complexity – COVID-19 Testing in School With Children and Staff: Complete Statistical AnalysisIndependent statistical analysis of ReSET Aim 1b: Restarting Safe Education and Testing for Children With Medical Complexity - COVID-19 Testing in School With Children and Staff: primary endpoint results, effect estimate with…
- Residual Gastric Volume Measured by Ultrasound in Diabetic Surgical Population Versus Non-diabetic Surgical Population.: Complete Statistical AnalysisIndependent statistical analysis of Residual Gastric Volume Measured by Ultrasound in Diabetic Surgical Population Versus Non-diabetic Surgical Population.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- RESISTIndependent statistical analysis of Aspirin Resistance and Percutaneous Coronary Intervention (PCI): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01103440).
- RESISTIndependent statistical analysis of Remote Ischemic Conditioning in Patients With Acute Stroke (RESIST): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03481777).
- RESOLVEIndependent statistical analysis of Tailored Non-Pharmacotherapy Services for Chronic Pain: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04523714).
- Respiratory Muscle Training (RMT) in ALS: Complete Statistical AnalysisIndependent statistical analysis of Respiratory Muscle Training (RMT) in ALS: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04224961).
- Respiratory Syncytial Virus (RSV) Human Challenge Study of Molnupiravir in Healthy Participants (MK-4482-017): Complete Statistical AnalysisIndependent statistical analysis of Respiratory Syncytial Virus (RSV) Human Challenge Study of Molnupiravir in Healthy Participants (MK-4482-017): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- RESPIREIndependent statistical analysis of Evaluating Smoking Cessation Protocols in Cancer Patients: NRT, MI, CBT or Hypnotherapy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Response to Diaphragmatic Pacing in Subjects With Pompe Disease: Complete Statistical AnalysisIndependent statistical analysis of Response to Diaphragmatic Pacing in Subjects With Pompe Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02354651).
- Response to Intermittent Pneumatic Compression Therapy in Head and Neck Cancer-Related Lymphedema: Complete Statistical AnalysisIndependent statistical analysis of Response to Intermittent Pneumatic Compression Therapy in Head and Neck Cancer-Related Lymphedema: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Restasis for Treatment of Brittle Nails: Complete Statistical AnalysisIndependent statistical analysis of Restasis for Treatment of Brittle Nails: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00986427).
- Resting-State Neural Connectivity in Patients With Subjective Tinnitus Without Bother: Complete Statistical AnalysisIndependent statistical analysis of Resting-State Neural Connectivity in Patients With Subjective Tinnitus Without Bother: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01049828).
- RestorAATion-1Independent statistical analysis of A Phase 1 Research Study to Evaluate Safety, Tolerability, and Pharmacokinetics of WVE-006 in Healthy Participants With Wild-type AAT Expression (RestorAATion-1): primary endpoint results, effect estimate with confidence…
- RESTOREIndependent statistical analysis of A Study of Selexipag Assessing Right Ventricular Remodeling in Pulmonary Arterial Hypertension by Cardiac Magnetic Resonance Imaging: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- RestoreIndependent statistical analysis of RE-sensitizing With Supraphysiologic Testosterone to Overcome REsistance (The RESTORE Study): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02090114).
- ReSTOREIndependent statistical analysis of Study of Rezafungin Compared to Caspofungin in Subjects With Candidemia and/or Invasive Candidiasis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Restoring Cognitive Control (ReCon) in Acute Nicotine Withdrawal: Complete Statistical AnalysisIndependent statistical analysis of Restoring Cognitive Control (ReCon) in Acute Nicotine Withdrawal: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03887429).
- REsynchronization reVErses Remodeling in Systolic Left vEntricular Dysfunction (REVERSE): Complete Statistical AnalysisIndependent statistical analysis of REsynchronization reVErses Remodeling in Systolic Left vEntricular Dysfunction (REVERSE): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00271154).
- RETHINCIndependent statistical analysis of RETHINC: REdefining THerapy In Early COPD for the Pulmonary Trials Cooperative: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- ReTHINKIndependent statistical analysis of Phase III Study Investigating the Efficacy and Safety of Ruxolitinib in Early Myelofibrosis Patients With High Molecular Risk Mutations.: primary endpoint results, effect estimate with confidence interval, sample-size…